Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for ID4_TCF4_SNAI2
Z-value: 2.26
Motif logo
Transcription factors associated with ID4_TCF4_SNAI2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ID4
|
ENSG00000172201.6 | inhibitor of DNA binding 4, HLH protein |
|
TCF4
|
ENSG00000196628.9 | transcription factor 4 |
|
SNAI2
|
ENSG00000019549.4 | snail family transcriptional repressor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ID4 | hg19_v2_chr6_+_19837592_19837621 | 0.93 | 2.6e-13 | Click! |
| TCF4 | hg19_v2_chr18_-_53303123_53303190 | 0.85 | 3.2e-09 | Click! |
| SNAI2 | hg19_v2_chr8_-_49833978_49833996, hg19_v2_chr8_-_49834299_49834446 | -0.81 | 7.2e-08 | Click! |
Activity profile of ID4_TCF4_SNAI2 motif
Sorted Z-values of ID4_TCF4_SNAI2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr4_-_16085340 | 24.18 |
ENST00000508167.1
|
PROM1
|
prominin 1 |
| chr4_-_16085314 | 24.16 |
ENST00000510224.1
|
PROM1
|
prominin 1 |
| chr5_+_156693091 | 18.58 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr5_+_156693159 | 18.26 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr7_-_73184588 | 16.10 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr1_-_75139397 | 12.99 |
ENST00000326665.5
|
C1orf173
|
chromosome 1 open reading frame 173 |
| chr10_+_22634384 | 12.87 |
ENST00000376624.3
ENST00000376603.2 ENST00000376601.1 ENST00000538630.1 ENST00000456231.2 ENST00000313311.6 ENST00000435326.1 |
SPAG6
|
sperm associated antigen 6 |
| chr3_+_63638339 | 12.51 |
ENST00000343837.3
ENST00000469440.1 |
SNTN
|
sentan, cilia apical structure protein |
| chr16_+_67465016 | 12.18 |
ENST00000326152.5
|
HSD11B2
|
hydroxysteroid (11-beta) dehydrogenase 2 |
| chr22_-_50970506 | 11.76 |
ENST00000428989.2
ENST00000403326.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr1_+_60280458 | 11.56 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr3_-_50383096 | 10.73 |
ENST00000442887.1
ENST00000360165.3 |
ZMYND10
|
zinc finger, MYND-type containing 10 |
| chr4_-_149363662 | 10.53 |
ENST00000355292.3
ENST00000358102.3 |
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
| chr21_+_42688657 | 10.45 |
ENST00000357985.2
|
FAM3B
|
family with sequence similarity 3, member B |
| chr1_+_118148556 | 10.12 |
ENST00000369448.3
|
FAM46C
|
family with sequence similarity 46, member C |
| chr9_-_138391692 | 10.12 |
ENST00000429260.2
|
C9orf116
|
chromosome 9 open reading frame 116 |
| chr9_-_75567962 | 9.85 |
ENST00000297785.3
ENST00000376939.1 |
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1 |
| chr8_-_110656995 | 9.70 |
ENST00000276646.9
ENST00000533065.1 |
SYBU
|
syntabulin (syntaxin-interacting) |
| chr16_-_776431 | 8.95 |
ENST00000293889.6
|
CCDC78
|
coiled-coil domain containing 78 |
| chr2_+_228735763 | 8.95 |
ENST00000373666.2
|
DAW1
|
dynein assembly factor with WDR repeat domains 1 |
| chr11_+_86511549 | 8.27 |
ENST00000533902.2
|
PRSS23
|
protease, serine, 23 |
| chr3_-_121740969 | 8.21 |
ENST00000393631.1
ENST00000273691.3 ENST00000344209.5 |
ILDR1
|
immunoglobulin-like domain containing receptor 1 |
| chr14_+_96949319 | 8.08 |
ENST00000554706.1
|
AK7
|
adenylate kinase 7 |
| chr7_-_131241361 | 8.02 |
ENST00000378555.3
ENST00000322985.9 ENST00000541194.1 ENST00000537928.1 |
PODXL
|
podocalyxin-like |
| chr1_-_207119738 | 8.00 |
ENST00000356495.4
|
PIGR
|
polymeric immunoglobulin receptor |
| chr21_+_42688686 | 7.96 |
ENST00000398652.3
ENST00000398647.3 |
FAM3B
|
family with sequence similarity 3, member B |
| chr1_-_57285038 | 7.78 |
ENST00000343433.6
|
C1orf168
|
chromosome 1 open reading frame 168 |
| chr14_+_67999999 | 7.74 |
ENST00000329153.5
|
PLEKHH1
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
| chr12_-_25348007 | 7.74 |
ENST00000354189.5
ENST00000545133.1 ENST00000554347.1 ENST00000395987.3 ENST00000320267.9 ENST00000395990.2 ENST00000537577.1 |
CASC1
|
cancer susceptibility candidate 1 |
| chr14_-_100625932 | 7.60 |
ENST00000553834.1
|
DEGS2
|
delta(4)-desaturase, sphingolipid 2 |
| chr12_-_71551868 | 7.56 |
ENST00000247829.3
|
TSPAN8
|
tetraspanin 8 |
| chr11_+_27062860 | 7.55 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr19_-_55677920 | 7.43 |
ENST00000524407.2
ENST00000526003.1 ENST00000534170.1 |
DNAAF3
|
dynein, axonemal, assembly factor 3 |
| chr19_-_7990991 | 7.40 |
ENST00000318978.4
|
CTXN1
|
cortexin 1 |
| chr17_-_46035187 | 7.28 |
ENST00000300557.2
|
PRR15L
|
proline rich 15-like |
| chr15_+_50474385 | 7.27 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr5_-_35938674 | 7.26 |
ENST00000397366.1
ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL
|
calcyphosine-like |
| chr20_+_31870927 | 7.13 |
ENST00000253354.1
|
BPIFB1
|
BPI fold containing family B, member 1 |
| chr11_+_27062272 | 7.10 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr2_-_230579185 | 7.04 |
ENST00000341772.4
|
DNER
|
delta/notch-like EGF repeat containing |
| chr12_-_71551652 | 6.93 |
ENST00000546561.1
|
TSPAN8
|
tetraspanin 8 |
| chr14_-_107078851 | 6.92 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr15_+_82555125 | 6.90 |
ENST00000566205.1
ENST00000339465.5 ENST00000569120.1 ENST00000566861.1 |
FAM154B
|
family with sequence similarity 154, member B |
| chr16_+_811073 | 6.87 |
ENST00000382862.3
ENST00000563651.1 |
MSLN
|
mesothelin |
| chr4_-_177116772 | 6.84 |
ENST00000280191.2
|
SPATA4
|
spermatogenesis associated 4 |
| chr11_-_26593779 | 6.76 |
ENST00000529533.1
|
MUC15
|
mucin 15, cell surface associated |
| chr11_+_27062502 | 6.68 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr1_-_183622442 | 6.58 |
ENST00000308641.4
|
APOBEC4
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative) |
| chr15_+_50474412 | 6.52 |
ENST00000380902.4
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr16_+_84178874 | 6.46 |
ENST00000378553.5
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
| chr16_-_1968231 | 6.46 |
ENST00000443547.1
ENST00000293937.3 ENST00000454677.2 |
HS3ST6
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 6 |
| chr7_-_120497178 | 6.39 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
| chr17_-_72968809 | 6.32 |
ENST00000530857.1
ENST00000425042.2 |
HID1
|
HID1 domain containing |
| chr19_-_55677999 | 6.31 |
ENST00000532817.1
ENST00000527223.2 ENST00000391720.4 |
DNAAF3
|
dynein, axonemal, assembly factor 3 |
| chr9_-_80263220 | 6.28 |
ENST00000341700.6
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14 |
| chr4_+_75858318 | 6.27 |
ENST00000307428.7
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
| chr1_-_223537475 | 6.22 |
ENST00000344029.6
ENST00000494793.2 ENST00000366878.4 ENST00000366877.3 |
SUSD4
|
sushi domain containing 4 |
| chr16_+_2880157 | 6.13 |
ENST00000382280.3
|
ZG16B
|
zymogen granule protein 16B |
| chr1_-_223537401 | 6.02 |
ENST00000343846.3
ENST00000454695.2 ENST00000484758.2 |
SUSD4
|
sushi domain containing 4 |
| chr12_-_68726052 | 5.96 |
ENST00000540418.1
ENST00000411698.2 ENST00000393543.3 ENST00000303145.7 |
MDM1
|
Mdm1 nuclear protein homolog (mouse) |
| chr16_+_616995 | 5.95 |
ENST00000293874.2
ENST00000409527.2 ENST00000424439.2 ENST00000540585.1 |
PIGQ
NHLRC4
|
phosphatidylinositol glycan anchor biosynthesis, class Q NHL repeat containing 4 |
| chr16_+_2880254 | 5.85 |
ENST00000570670.1
|
ZG16B
|
zymogen granule protein 16B |
| chr6_-_32498046 | 5.85 |
ENST00000374975.3
|
HLA-DRB5
|
major histocompatibility complex, class II, DR beta 5 |
| chr11_-_108464465 | 5.84 |
ENST00000525344.1
|
EXPH5
|
exophilin 5 |
| chr7_+_29603394 | 5.82 |
ENST00000319694.2
|
PRR15
|
proline rich 15 |
| chr19_-_3025614 | 5.79 |
ENST00000447365.2
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
| chr14_-_106642049 | 5.63 |
ENST00000390605.2
|
IGHV1-18
|
immunoglobulin heavy variable 1-18 |
| chr4_+_1003742 | 5.62 |
ENST00000398484.2
|
FGFRL1
|
fibroblast growth factor receptor-like 1 |
| chr19_-_9092018 | 5.61 |
ENST00000397910.4
|
MUC16
|
mucin 16, cell surface associated |
| chr17_+_73521763 | 5.59 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
| chr11_-_26593649 | 5.58 |
ENST00000455601.2
|
MUC15
|
mucin 15, cell surface associated |
| chr6_-_32557610 | 5.58 |
ENST00000360004.5
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1 |
| chr8_+_99076750 | 5.57 |
ENST00000545282.1
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr19_-_3029011 | 5.54 |
ENST00000590536.1
ENST00000587137.1 ENST00000455444.2 ENST00000262953.6 |
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
| chr11_-_26593677 | 5.54 |
ENST00000527569.1
|
MUC15
|
mucin 15, cell surface associated |
| chr13_+_35516390 | 5.50 |
ENST00000540320.1
ENST00000400445.3 ENST00000310336.4 |
NBEA
|
neurobeachin |
| chr18_-_24765248 | 5.50 |
ENST00000580774.1
ENST00000284224.8 |
CHST9
|
carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 9 |
| chr5_-_149792295 | 5.48 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
| chr11_-_34535297 | 5.41 |
ENST00000532417.1
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
| chr22_-_50970566 | 5.40 |
ENST00000405135.1
ENST00000401779.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr11_-_34535332 | 5.38 |
ENST00000257832.2
ENST00000429939.2 |
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
| chr1_-_46089639 | 5.34 |
ENST00000445048.2
|
CCDC17
|
coiled-coil domain containing 17 |
| chr2_+_205410516 | 5.28 |
ENST00000406610.2
ENST00000462231.1 |
PARD3B
|
par-3 family cell polarity regulator beta |
| chr1_+_18807424 | 5.21 |
ENST00000400664.1
|
KLHDC7A
|
kelch domain containing 7A |
| chr8_+_99076509 | 5.19 |
ENST00000318528.3
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr19_+_41620335 | 5.19 |
ENST00000331105.2
|
CYP2F1
|
cytochrome P450, family 2, subfamily F, polypeptide 1 |
| chr10_+_12391481 | 5.14 |
ENST00000378847.3
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID |
| chr2_-_154335300 | 5.09 |
ENST00000325926.3
|
RPRM
|
reprimo, TP53 dependent G2 arrest mediator candidate |
| chr22_-_50970919 | 5.05 |
ENST00000329363.4
ENST00000437588.1 |
ODF3B
|
outer dense fiber of sperm tails 3B |
| chr10_+_94608245 | 5.00 |
ENST00000443748.2
ENST00000260762.6 |
EXOC6
|
exocyst complex component 6 |
| chr17_-_4463856 | 4.99 |
ENST00000574584.1
ENST00000381550.3 ENST00000301395.3 |
GGT6
|
gamma-glutamyltransferase 6 |
| chr17_-_40346477 | 4.88 |
ENST00000593209.1
ENST00000587427.1 ENST00000588352.1 ENST00000414034.3 ENST00000590249.1 |
GHDC
|
GH3 domain containing |
| chr18_-_71815051 | 4.85 |
ENST00000582526.1
ENST00000419743.2 |
FBXO15
|
F-box protein 15 |
| chr6_+_116937636 | 4.85 |
ENST00000368581.4
ENST00000229554.5 ENST00000368580.4 |
RSPH4A
|
radial spoke head 4 homolog A (Chlamydomonas) |
| chr11_+_6260298 | 4.83 |
ENST00000379936.2
|
CNGA4
|
cyclic nucleotide gated channel alpha 4 |
| chr11_-_108464321 | 4.83 |
ENST00000265843.4
|
EXPH5
|
exophilin 5 |
| chr16_+_71560154 | 4.76 |
ENST00000539698.3
|
CHST4
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 |
| chr16_+_4784273 | 4.73 |
ENST00000299320.5
ENST00000586724.1 |
C16orf71
|
chromosome 16 open reading frame 71 |
| chr2_-_86564776 | 4.72 |
ENST00000165698.5
ENST00000541910.1 ENST00000535845.1 |
REEP1
|
receptor accessory protein 1 |
| chr16_+_71560023 | 4.71 |
ENST00000572450.1
|
CHST4
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 4 |
| chr10_+_92980517 | 4.68 |
ENST00000336126.5
|
PCGF5
|
polycomb group ring finger 5 |
| chr5_-_180018540 | 4.68 |
ENST00000292641.3
|
SCGB3A1
|
secretoglobin, family 3A, member 1 |
| chr14_+_77564440 | 4.61 |
ENST00000361786.2
ENST00000555437.1 ENST00000555611.1 ENST00000554658.1 |
KIAA1737
|
CLOCK-interacting pacemaker |
| chr3_+_13610216 | 4.59 |
ENST00000492059.1
|
FBLN2
|
fibulin 2 |
| chr3_+_111393659 | 4.58 |
ENST00000477665.1
|
PLCXD2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
| chr16_+_4784458 | 4.58 |
ENST00000590191.1
|
C16orf71
|
chromosome 16 open reading frame 71 |
| chr6_-_130031358 | 4.56 |
ENST00000368149.2
|
ARHGAP18
|
Rho GTPase activating protein 18 |
| chr9_-_126030817 | 4.52 |
ENST00000348403.5
ENST00000447404.2 ENST00000360998.3 |
STRBP
|
spermatid perinuclear RNA binding protein |
| chr17_-_4689649 | 4.51 |
ENST00000441199.2
ENST00000416307.2 |
VMO1
|
vitelline membrane outer layer 1 homolog (chicken) |
| chr12_-_63328817 | 4.50 |
ENST00000228705.6
|
PPM1H
|
protein phosphatase, Mg2+/Mn2+ dependent, 1H |
| chr8_-_141467818 | 4.47 |
ENST00000389327.3
ENST00000438773.2 |
TRAPPC9
|
trafficking protein particle complex 9 |
| chr7_+_150065278 | 4.45 |
ENST00000519397.1
ENST00000479668.1 ENST00000540729.1 |
REPIN1
|
replication initiator 1 |
| chr11_+_73358594 | 4.44 |
ENST00000227214.6
ENST00000398494.4 ENST00000543085.1 |
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
| chr19_+_14544099 | 4.42 |
ENST00000242783.6
ENST00000586557.1 ENST00000590097.1 |
PKN1
|
protein kinase N1 |
| chr15_-_52587945 | 4.42 |
ENST00000443683.2
ENST00000558479.1 ENST00000261839.7 |
MYO5C
|
myosin VC |
| chr9_+_17579084 | 4.40 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
| chr15_+_78558523 | 4.40 |
ENST00000446172.2
|
DNAJA4
|
DnaJ (Hsp40) homolog, subfamily A, member 4 |
| chr2_-_31030277 | 4.39 |
ENST00000534090.2
ENST00000295055.8 |
CAPN13
|
calpain 13 |
| chr2_-_239148599 | 4.37 |
ENST00000409182.1
ENST00000409002.3 ENST00000450098.1 ENST00000409356.1 ENST00000409160.3 ENST00000409574.1 ENST00000272937.5 |
HES6
|
hes family bHLH transcription factor 6 |
| chr18_-_71814999 | 4.37 |
ENST00000269500.5
|
FBXO15
|
F-box protein 15 |
| chr15_-_56757329 | 4.36 |
ENST00000260453.3
|
MNS1
|
meiosis-specific nuclear structural 1 |
| chr7_-_16921601 | 4.36 |
ENST00000402239.3
ENST00000310398.2 ENST00000414935.1 |
AGR3
|
anterior gradient 3 |
| chr1_-_46089718 | 4.36 |
ENST00000421127.2
ENST00000343901.2 ENST00000528266.1 |
CCDC17
|
coiled-coil domain containing 17 |
| chr17_+_1633755 | 4.30 |
ENST00000545662.1
|
WDR81
|
WD repeat domain 81 |
| chr17_-_6947225 | 4.25 |
ENST00000574600.1
ENST00000308009.1 ENST00000447225.1 |
SLC16A11
|
solute carrier family 16, member 11 |
| chr15_-_48470544 | 4.24 |
ENST00000267836.6
|
MYEF2
|
myelin expression factor 2 |
| chr4_-_38806404 | 4.23 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
| chr16_+_84209539 | 4.22 |
ENST00000569735.1
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
| chr14_+_75536335 | 4.20 |
ENST00000554763.1
ENST00000439583.2 ENST00000526130.1 ENST00000525046.1 |
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
| chr5_+_169532896 | 4.19 |
ENST00000306268.6
ENST00000449804.2 |
FOXI1
|
forkhead box I1 |
| chr14_+_75536280 | 4.16 |
ENST00000238686.8
|
ZC2HC1C
|
zinc finger, C2HC-type containing 1C |
| chr3_-_15643060 | 4.15 |
ENST00000414979.1
ENST00000435217.2 ENST00000456194.2 ENST00000457447.2 |
HACL1
|
2-hydroxyacyl-CoA lyase 1 |
| chr19_-_54676884 | 4.11 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
| chr8_-_17270809 | 4.10 |
ENST00000180173.5
ENST00000521857.1 |
MTMR7
|
myotubularin related protein 7 |
| chr2_+_10861775 | 4.10 |
ENST00000272238.4
ENST00000381661.3 |
ATP6V1C2
|
ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 |
| chr1_+_3607228 | 4.08 |
ENST00000378285.1
ENST00000378280.1 ENST00000378288.4 |
TP73
|
tumor protein p73 |
| chr7_+_44788430 | 4.08 |
ENST00000457123.1
ENST00000309315.4 |
ZMIZ2
|
zinc finger, MIZ-type containing 2 |
| chr11_-_34533257 | 4.02 |
ENST00000312319.2
|
ELF5
|
E74-like factor 5 (ets domain transcription factor) |
| chr20_+_56725952 | 4.00 |
ENST00000371168.3
|
C20orf85
|
chromosome 20 open reading frame 85 |
| chr19_-_47137942 | 3.97 |
ENST00000300873.4
|
GNG8
|
guanine nucleotide binding protein (G protein), gamma 8 |
| chr19_+_41594377 | 3.96 |
ENST00000330436.3
|
CYP2A13
|
cytochrome P450, family 2, subfamily A, polypeptide 13 |
| chr14_-_53019211 | 3.96 |
ENST00000557374.1
ENST00000281741.4 |
TXNDC16
|
thioredoxin domain containing 16 |
| chr15_+_81426588 | 3.95 |
ENST00000286732.4
|
C15orf26
|
chromosome 15 open reading frame 26 |
| chr11_+_71903169 | 3.94 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
| chr2_-_238499303 | 3.93 |
ENST00000409576.1
|
RAB17
|
RAB17, member RAS oncogene family |
| chr22_-_36013368 | 3.93 |
ENST00000442617.1
ENST00000397326.2 ENST00000397328.1 ENST00000451685.1 |
MB
|
myoglobin |
| chr14_-_67982146 | 3.91 |
ENST00000557779.1
ENST00000557006.1 |
TMEM229B
|
transmembrane protein 229B |
| chr19_-_54676846 | 3.89 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
| chr21_-_46330545 | 3.88 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr16_-_67427389 | 3.84 |
ENST00000562206.1
ENST00000290942.5 ENST00000393957.2 |
TPPP3
|
tubulin polymerization-promoting protein family member 3 |
| chr2_+_223289208 | 3.83 |
ENST00000321276.7
|
SGPP2
|
sphingosine-1-phosphate phosphatase 2 |
| chr12_+_56661033 | 3.80 |
ENST00000433805.2
|
COQ10A
|
coenzyme Q10 homolog A (S. cerevisiae) |
| chr9_+_72435709 | 3.78 |
ENST00000377197.3
ENST00000527647.1 |
C9orf135
|
chromosome 9 open reading frame 135 |
| chr5_-_43412418 | 3.77 |
ENST00000537013.1
ENST00000361115.4 |
CCL28
|
chemokine (C-C motif) ligand 28 |
| chr1_+_12806141 | 3.73 |
ENST00000288048.5
|
C1orf158
|
chromosome 1 open reading frame 158 |
| chr17_-_6735035 | 3.73 |
ENST00000338694.2
|
TEKT1
|
tektin 1 |
| chr4_+_75858290 | 3.72 |
ENST00000513238.1
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
| chr12_+_56473628 | 3.71 |
ENST00000549282.1
ENST00000549061.1 ENST00000267101.3 |
ERBB3
|
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 |
| chr6_+_109169591 | 3.69 |
ENST00000368972.3
ENST00000392644.4 |
ARMC2
|
armadillo repeat containing 2 |
| chr11_+_1855645 | 3.69 |
ENST00000381968.3
ENST00000381978.3 |
SYT8
|
synaptotagmin VIII |
| chr6_+_138483058 | 3.69 |
ENST00000251691.4
|
KIAA1244
|
KIAA1244 |
| chr3_-_15643090 | 3.66 |
ENST00000451445.2
ENST00000421993.1 |
HACL1
|
2-hydroxyacyl-CoA lyase 1 |
| chr10_+_12391685 | 3.64 |
ENST00000378845.1
|
CAMK1D
|
calcium/calmodulin-dependent protein kinase ID |
| chr6_+_52285131 | 3.61 |
ENST00000433625.2
|
EFHC1
|
EF-hand domain (C-terminal) containing 1 |
| chr5_-_150603679 | 3.61 |
ENST00000355417.2
|
CCDC69
|
coiled-coil domain containing 69 |
| chr16_+_19422035 | 3.60 |
ENST00000381414.4
ENST00000396229.2 |
TMC5
|
transmembrane channel-like 5 |
| chr16_-_74808710 | 3.58 |
ENST00000219368.3
ENST00000544337.1 |
FA2H
|
fatty acid 2-hydroxylase |
| chr4_+_55524085 | 3.53 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
| chr3_-_49170405 | 3.53 |
ENST00000305544.4
ENST00000494831.1 |
LAMB2
|
laminin, beta 2 (laminin S) |
| chr16_-_3086927 | 3.53 |
ENST00000572449.1
|
CCDC64B
|
coiled-coil domain containing 64B |
| chr5_+_140019004 | 3.53 |
ENST00000394671.3
ENST00000511410.1 ENST00000537378.1 |
TMCO6
|
transmembrane and coiled-coil domains 6 |
| chr17_+_26800296 | 3.51 |
ENST00000444914.3
ENST00000314669.5 |
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
| chr7_+_48494660 | 3.49 |
ENST00000411975.1
ENST00000544596.1 |
ABCA13
|
ATP-binding cassette, sub-family A (ABC1), member 13 |
| chr4_+_129732467 | 3.48 |
ENST00000413543.2
|
PHF17
|
jade family PHD finger 1 |
| chr6_+_39760783 | 3.48 |
ENST00000398904.2
ENST00000538976.1 |
DAAM2
|
dishevelled associated activator of morphogenesis 2 |
| chr1_+_95582881 | 3.48 |
ENST00000370203.4
ENST00000456991.1 |
TMEM56
|
transmembrane protein 56 |
| chr14_+_77582905 | 3.48 |
ENST00000557408.1
|
TMEM63C
|
transmembrane protein 63C |
| chr15_+_41062159 | 3.48 |
ENST00000344320.6
|
C15orf62
|
chromosome 15 open reading frame 62 |
| chr4_+_25657444 | 3.48 |
ENST00000504570.1
ENST00000382051.3 |
SLC34A2
|
solute carrier family 34 (type II sodium/phosphate contransporter), member 2 |
| chr16_+_66400533 | 3.47 |
ENST00000341529.3
|
CDH5
|
cadherin 5, type 2 (vascular endothelium) |
| chr5_+_78532003 | 3.46 |
ENST00000396137.4
|
JMY
|
junction mediating and regulatory protein, p53 cofactor |
| chr14_-_67981916 | 3.45 |
ENST00000357461.2
|
TMEM229B
|
transmembrane protein 229B |
| chr11_+_2466218 | 3.45 |
ENST00000155840.5
|
KCNQ1
|
potassium voltage-gated channel, KQT-like subfamily, member 1 |
| chrX_+_106449862 | 3.44 |
ENST00000372453.3
ENST00000535523.1 |
PIH1D3
|
PIH1 domain containing 3 |
| chr7_-_99573640 | 3.44 |
ENST00000411734.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr2_+_120187465 | 3.41 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
| chr10_-_98480243 | 3.41 |
ENST00000339364.5
|
PIK3AP1
|
phosphoinositide-3-kinase adaptor protein 1 |
| chr17_+_26800648 | 3.39 |
ENST00000545060.1
|
SLC13A2
|
solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 |
| chr16_+_25228242 | 3.39 |
ENST00000219660.5
|
AQP8
|
aquaporin 8 |
| chr17_-_8702667 | 3.35 |
ENST00000329805.4
|
MFSD6L
|
major facilitator superfamily domain containing 6-like |
| chr10_+_114169299 | 3.34 |
ENST00000369410.3
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr19_-_41388657 | 3.34 |
ENST00000301146.4
ENST00000291764.3 |
CYP2A7
|
cytochrome P450, family 2, subfamily A, polypeptide 7 |
| chr10_-_28287968 | 3.34 |
ENST00000305242.5
|
ARMC4
|
armadillo repeat containing 4 |
| chr5_+_140019079 | 3.33 |
ENST00000252100.6
|
TMCO6
|
transmembrane and coiled-coil domains 6 |
| chr11_+_1874200 | 3.32 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
| chr9_-_97401782 | 3.31 |
ENST00000375326.4
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
| chr11_+_1942580 | 3.31 |
ENST00000381558.1
|
TNNT3
|
troponin T type 3 (skeletal, fast) |
| chr19_+_54058073 | 3.29 |
ENST00000505949.1
ENST00000513265.1 |
ZNF331
|
zinc finger protein 331 |
| chr13_+_50589390 | 3.29 |
ENST00000360473.4
ENST00000312942.1 |
KCNRG
|
potassium channel regulator |
| chr16_+_2880369 | 3.29 |
ENST00000572863.1
|
ZG16B
|
zymogen granule protein 16B |
Network of associatons between targets according to the STRING database.
First level regulatory network of ID4_TCF4_SNAI2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.1 | 48.3 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 4.0 | 20.2 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 3.6 | 36.4 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 3.4 | 13.8 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 2.9 | 2.9 | GO:0034340 | response to type I interferon(GO:0034340) |
| 2.6 | 7.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 2.4 | 9.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 2.2 | 13.0 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 2.0 | 8.0 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.8 | 11.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 1.8 | 20.2 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 1.6 | 4.9 | GO:0033212 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 1.6 | 6.3 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 1.6 | 4.7 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.4 | 44.0 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 1.4 | 4.2 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 1.3 | 4.0 | GO:0042495 | detection of triacyl bacterial lipopeptide(GO:0042495) detection of bacterial lipopeptide(GO:0070340) |
| 1.3 | 3.9 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.3 | 9.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.2 | 3.7 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 1.2 | 3.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.2 | 3.7 | GO:1901739 | regulation of syncytium formation by plasma membrane fusion(GO:0060142) regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
| 1.2 | 4.7 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 1.1 | 5.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.1 | 4.6 | GO:0090299 | regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 1.1 | 1.1 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 1.1 | 5.6 | GO:0002399 | MHC class II protein complex assembly(GO:0002399) |
| 1.1 | 3.3 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 1.1 | 8.8 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 1.1 | 3.2 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 1.1 | 3.2 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 1.0 | 5.2 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 1.0 | 11.2 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 1.0 | 3.0 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 1.0 | 9.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 1.0 | 6.9 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 1.0 | 5.8 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 1.0 | 3.8 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 1.0 | 3.8 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 0.9 | 6.5 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.9 | 2.7 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.9 | 3.6 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.9 | 0.9 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.9 | 1.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.9 | 3.4 | GO:2000690 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.9 | 11.1 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.8 | 2.5 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.8 | 4.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.8 | 1.7 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.8 | 14.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.8 | 2.4 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.8 | 0.8 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.8 | 1.6 | GO:0002086 | diaphragm contraction(GO:0002086) |
| 0.8 | 2.3 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.8 | 3.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.8 | 6.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.7 | 0.7 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.7 | 2.2 | GO:0061054 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 0.7 | 3.7 | GO:0000023 | maltose metabolic process(GO:0000023) |
| 0.7 | 7.3 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.7 | 0.7 | GO:0071426 | ribonucleoprotein complex localization(GO:0071166) ribonucleoprotein complex export from nucleus(GO:0071426) |
| 0.7 | 5.6 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.7 | 2.1 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.7 | 2.0 | GO:0021571 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.7 | 16.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.7 | 3.4 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.7 | 2.7 | GO:0072134 | nephrogenic mesenchyme morphogenesis(GO:0072134) allantois development(GO:1905069) |
| 0.7 | 0.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 0.7 | 2.0 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.7 | 2.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.7 | 2.6 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 0.6 | 3.2 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.6 | 1.3 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 0.6 | 4.5 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.6 | 1.3 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.6 | 1.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.6 | 8.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 0.6 | 0.6 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.6 | 8.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.6 | 1.8 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.6 | 1.8 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 | 6.7 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.6 | 3.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.6 | 1.8 | GO:0060122 | auditory receptor cell stereocilium organization(GO:0060088) inner ear receptor stereocilium organization(GO:0060122) |
| 0.6 | 12.7 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.6 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.6 | 1.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
| 0.6 | 2.8 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.6 | 4.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.6 | 3.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.6 | 1.7 | GO:0035377 | transepithelial water transport(GO:0035377) positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 0.6 | 3.4 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.6 | 3.9 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.5 | 1.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.5 | 2.2 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
| 0.5 | 1.6 | GO:0044691 | tooth eruption(GO:0044691) |
| 0.5 | 2.7 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 0.5 | 8.5 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.5 | 2.7 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.5 | 2.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.5 | 5.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.5 | 12.4 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.5 | 3.1 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
| 0.5 | 3.1 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 0.5 | 1.5 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.5 | 1.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 0.5 | 1.5 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 0.5 | 4.5 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.5 | 1.5 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.5 | 2.5 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.5 | 1.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.5 | 14.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.5 | 3.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.5 | 2.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.5 | 1.0 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.5 | 0.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 0.5 | 10.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.5 | 2.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.5 | 0.5 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.5 | 1.4 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 0.5 | 1.4 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.5 | 1.4 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.5 | 1.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.5 | 18.1 | GO:0003341 | cilium movement(GO:0003341) |
| 0.5 | 1.0 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
| 0.5 | 3.3 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.5 | 1.4 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 0.5 | 4.2 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.5 | 1.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.5 | 1.8 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 0.5 | 6.5 | GO:0015866 | ADP transport(GO:0015866) |
| 0.5 | 1.8 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 0.4 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.4 | 1.3 | GO:0098727 | maintenance of cell number(GO:0098727) |
| 0.4 | 2.7 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.4 | 1.3 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.4 | 7.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.4 | 0.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.4 | 0.9 | GO:0052314 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
| 0.4 | 1.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 | 0.4 | GO:1902991 | regulation of beta-amyloid formation(GO:1902003) regulation of amyloid precursor protein catabolic process(GO:1902991) |
| 0.4 | 3.4 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
| 0.4 | 1.3 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.4 | 8.9 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.4 | 2.5 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.4 | 2.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.4 | 1.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.4 | 2.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.4 | 9.9 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.4 | 1.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.4 | 1.6 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 0.4 | 1.2 | GO:0090345 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.4 | 1.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
| 0.4 | 0.8 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 0.4 | 3.5 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.4 | 2.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) embryonic hindgut morphogenesis(GO:0048619) |
| 0.4 | 2.3 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.4 | 3.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.4 | 1.9 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 0.4 | 30.9 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.4 | 2.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.4 | 1.1 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.4 | 1.5 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.4 | 0.4 | GO:0030167 | proteoglycan catabolic process(GO:0030167) heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.4 | 3.0 | GO:0032439 | endosome localization(GO:0032439) |
| 0.4 | 1.1 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 0.4 | 2.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.4 | 1.1 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 0.4 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.4 | 2.2 | GO:0061525 | hindgut development(GO:0061525) |
| 0.4 | 0.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.4 | 1.1 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
| 0.4 | 1.1 | GO:0043474 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.4 | 1.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 | 0.4 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.4 | 1.4 | GO:0043335 | protein unfolding(GO:0043335) |
| 0.4 | 2.1 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.4 | 2.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 0.4 | 1.4 | GO:0018032 | protein amidation(GO:0018032) |
| 0.4 | 3.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.3 | 1.0 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.3 | 0.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.3 | 5.2 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.3 | 1.4 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.3 | 1.0 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.3 | 1.4 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.3 | 0.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.3 | 0.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.3 | 18.1 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.3 | 1.0 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
| 0.3 | 1.0 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 | 1.3 | GO:0002155 | regulation of thyroid hormone mediated signaling pathway(GO:0002155) |
| 0.3 | 0.7 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.3 | 1.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 | 1.0 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.3 | 1.0 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.3 | 0.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 0.3 | 2.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.3 | 0.7 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.3 | 2.6 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
| 0.3 | 6.1 | GO:0036376 | sodium ion export from cell(GO:0036376) |
| 0.3 | 0.6 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.3 | 0.3 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.3 | 0.6 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.3 | 4.5 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.3 | 3.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.3 | 1.3 | GO:0046677 | response to antibiotic(GO:0046677) |
| 0.3 | 0.3 | GO:1903792 | negative regulation of anion transport(GO:1903792) negative regulation of chloride transport(GO:2001226) |
| 0.3 | 1.0 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.3 | 0.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.3 | 0.3 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 0.3 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 3.8 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
| 0.3 | 0.3 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.3 | 1.9 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 | 0.9 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.3 | 1.5 | GO:1901858 | regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.3 | 0.9 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.3 | 1.8 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.3 | 0.3 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.3 | 0.9 | GO:0044805 | late nucleophagy(GO:0044805) |
| 0.3 | 0.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.3 | 2.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.3 | 0.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
| 0.3 | 0.6 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.3 | 1.8 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.3 | 5.0 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.3 | 0.9 | GO:0097069 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.3 | 5.8 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 0.3 | 0.9 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 | 1.2 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 0.3 | 0.9 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.3 | 1.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 0.3 | 0.9 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 0.3 | 0.9 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.3 | 0.3 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.3 | 0.6 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.3 | 1.7 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.3 | 0.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.3 | 1.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.3 | 0.8 | GO:0060139 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.3 | 11.8 | GO:0090662 | ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.3 | 1.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 | 0.6 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.3 | 1.1 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 | 3.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.3 | 1.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 0.3 | 1.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 | 1.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.3 | 5.3 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.3 | 2.1 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
| 0.3 | 0.8 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
| 0.3 | 1.0 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.3 | 0.8 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.3 | 1.3 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.3 | 1.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.3 | 0.8 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.3 | 0.5 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.3 | 5.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.3 | 0.5 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.3 | 0.3 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
| 0.3 | 1.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.3 | 1.8 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
| 0.3 | 4.3 | GO:0019374 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
| 0.3 | 0.8 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.2 | 4.7 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.2 | 0.7 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.2 | 0.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 0.2 | 1.2 | GO:0001757 | somite specification(GO:0001757) |
| 0.2 | 2.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.2 | 1.0 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
| 0.2 | 0.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.2 | 0.7 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) negative regulation of immunological synapse formation(GO:2000521) |
| 0.2 | 9.3 | GO:0042026 | protein refolding(GO:0042026) |
| 0.2 | 2.2 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.2 | 0.2 | GO:0071435 | potassium ion export(GO:0071435) |
| 0.2 | 1.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 | 0.2 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.2 | 0.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.2 | 0.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.2 | 0.7 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 0.2 | 2.4 | GO:0070269 | pyroptosis(GO:0070269) |
| 0.2 | 0.2 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 0.2 | 0.7 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.2 | 1.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.2 | 1.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 | 1.4 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.2 | 1.4 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 | 0.5 | GO:0014063 | regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.2 | 1.6 | GO:0098706 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 | 0.9 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 2.5 | GO:0003373 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 | 2.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.2 | 0.7 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
| 0.2 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 | 3.9 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.2 | 0.7 | GO:0072554 | blood vessel lumenization(GO:0072554) |
| 0.2 | 0.2 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) |
| 0.2 | 1.4 | GO:0009624 | response to nematode(GO:0009624) |
| 0.2 | 0.9 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.2 | 0.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.2 | 1.1 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.2 | 1.8 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.2 | 17.0 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 0.7 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.2 | 0.9 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 | 1.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 | 1.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.2 | 0.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.2 | 1.1 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
| 0.2 | 0.6 | GO:1903568 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.2 | 2.5 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.2 | 3.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 | 1.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 | 4.0 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.2 | 1.0 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 | 1.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.2 | 0.4 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.2 | 2.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.2 | 1.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.2 | 0.4 | GO:0009635 | response to herbicide(GO:0009635) |
| 0.2 | 1.0 | GO:0099624 | atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 | 5.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.2 | 0.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.2 | 0.6 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 0.2 | 1.2 | GO:0071503 | response to heparin(GO:0071503) |
| 0.2 | 0.6 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.2 | 10.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.2 | 0.6 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 | 2.2 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.2 | 0.8 | GO:0042048 | olfactory behavior(GO:0042048) |
| 0.2 | 1.4 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 1.8 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 0.2 | 1.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 | 4.5 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.2 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 0.6 | GO:0071899 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.2 | 1.2 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.2 | 0.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.2 | 1.0 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.2 | 0.6 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 0.2 | 1.6 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
| 0.2 | 1.2 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.2 | 8.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.2 | 3.7 | GO:0036315 | cellular response to sterol(GO:0036315) |
| 0.2 | 1.0 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.2 | 0.6 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.2 | 0.4 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 | 2.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 | 1.0 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 | 0.2 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.2 | 1.1 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.2 | 1.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 0.8 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.2 | 3.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.2 | 0.2 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 0.2 | 1.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.2 | 0.4 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 0.4 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
| 0.2 | 4.8 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.2 | 0.9 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 | 0.9 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
| 0.2 | 1.8 | GO:0071316 | cellular response to nicotine(GO:0071316) |
| 0.2 | 0.4 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.2 | 1.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.2 | 0.7 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.2 | 0.7 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.2 | 0.4 | GO:0070873 | regulation of polysaccharide metabolic process(GO:0032881) regulation of glycogen metabolic process(GO:0070873) |
| 0.2 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.2 | 2.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.2 | 0.4 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.2 | 3.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 | 0.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.2 | 0.9 | GO:0019075 | virus maturation(GO:0019075) |
| 0.2 | 0.2 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.2 | 0.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.2 | 0.4 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
| 0.2 | 0.4 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.2 | 1.2 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.2 | 1.0 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.2 | 4.6 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.2 | 1.0 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
| 0.2 | 2.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.5 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.2 | 0.5 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.2 | 0.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.2 | 1.7 | GO:0046146 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 | 0.8 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 0.2 | 2.5 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.2 | 0.2 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
| 0.2 | 1.5 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
| 0.2 | 1.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.2 | 7.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 | 2.8 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.2 | 0.8 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.2 | 0.5 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.2 | 1.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.2 | 0.5 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.2 | 0.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.2 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.2 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 | 0.6 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.2 | 2.6 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
| 0.2 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 | 0.8 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
| 0.2 | 0.8 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 1.4 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.2 | 1.3 | GO:0060613 | fat pad development(GO:0060613) |
| 0.2 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.2 | 0.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 | 0.6 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.2 | 0.8 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
| 0.2 | 0.8 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.2 | 0.6 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 | 1.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.2 | 0.3 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.2 | 0.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 | 1.4 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.2 | 0.5 | GO:1902896 | terminal web assembly(GO:1902896) |
| 0.2 | 0.5 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
| 0.2 | 1.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 1.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.2 | 0.5 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.2 | 0.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.1 | 0.4 | GO:0033555 | multicellular organismal response to stress(GO:0033555) |
| 0.1 | 0.9 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 | 2.1 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.1 | 0.3 | GO:1901074 | regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.1 | 1.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 1.3 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 2.0 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 1.0 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.1 | 0.9 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
| 0.1 | 0.6 | GO:0015732 | prostaglandin transport(GO:0015732) prostaglandin secretion(GO:0032310) |
| 0.1 | 0.1 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
| 0.1 | 0.7 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 0.1 | 0.3 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 0.1 | 0.4 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.1 | 1.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.1 | 0.7 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 0.1 | 0.4 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 0.1 | 0.6 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.1 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.1 | 0.6 | GO:0050975 | sensory perception of touch(GO:0050975) |
| 0.1 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.1 | 0.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.1 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.1 | 0.8 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.1 | 3.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 | 1.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.1 | 0.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.1 | 0.7 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.1 | 0.5 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.1 | 0.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.1 | 0.8 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.1 | 0.4 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.1 | 0.9 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 | 0.4 | GO:0051782 | negative regulation of cell division(GO:0051782) |
| 0.1 | 0.4 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.4 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 | 0.7 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 | 0.3 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 3.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.1 | 1.5 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
| 0.1 | 1.2 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 | 0.8 | GO:0032288 | myelin assembly(GO:0032288) |
| 0.1 | 0.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 0.1 | 0.3 | GO:2000397 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.1 | 0.4 | GO:2000173 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.1 | 1.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 1.3 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.1 | 2.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.1 | 0.5 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
| 0.1 | 0.4 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.5 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 0.1 | 0.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
| 0.1 | 0.5 | GO:0051291 | protein heterooligomerization(GO:0051291) |
| 0.1 | 0.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.4 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
| 0.1 | 3.5 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
| 0.1 | 0.5 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.1 | 0.3 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.1 | 1.3 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
| 0.1 | 2.1 | GO:0072189 | ureter development(GO:0072189) |
| 0.1 | 2.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
| 0.1 | 1.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.1 | 0.1 | GO:0003220 | left ventricular cardiac muscle tissue morphogenesis(GO:0003220) |
| 0.1 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.1 | 9.3 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.1 | 1.6 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 0.7 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 0.5 | GO:0051958 | methotrexate transport(GO:0051958) |
| 0.1 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 | 0.2 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 | 0.5 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 | 0.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.1 | 1.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 1.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 2.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 1.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.1 | 7.6 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 | 0.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
| 0.1 | 0.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 0.2 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.1 | 1.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.1 | 0.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 2.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 | 0.7 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
| 0.1 | 7.8 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 | 0.8 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 0.1 | 0.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.1 | 2.2 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.1 | 0.5 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 0.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 1.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 0.6 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 0.1 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 | 0.1 | GO:0006672 | ceramide metabolic process(GO:0006672) |
| 0.1 | 0.7 | GO:0006684 | sphingomyelin metabolic process(GO:0006684) |
| 0.1 | 1.1 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 0.2 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 0.1 | 0.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.1 | 1.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 0.1 | 0.9 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.1 | 0.3 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 | 0.3 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.1 | 0.7 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.1 | 0.3 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.1 | 0.8 | GO:0071027 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.1 | 0.4 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 | 0.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.2 | GO:0046326 | positive regulation of glucose transport(GO:0010828) positive regulation of glucose import(GO:0046326) |
| 0.1 | 0.7 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 | 0.8 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 | 0.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 0.1 | 0.3 | GO:2000329 | peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
| 0.1 | 0.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 0.1 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.1 | 0.1 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 | 0.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 | 1.3 | GO:0006506 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.7 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.7 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.1 | 0.1 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
| 0.1 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 | 0.3 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.1 | 0.1 | GO:0031627 | telomeric loop formation(GO:0031627) regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) |
| 0.1 | 2.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.1 | 0.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 0.6 | GO:0000086 | G2/M transition of mitotic cell cycle(GO:0000086) |
| 0.1 | 0.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 0.3 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.1 | 0.3 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.1 | 0.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 1.2 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.3 | GO:0019364 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 | 0.9 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 0.2 | GO:0015853 | adenine transport(GO:0015853) |
| 0.1 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 | 3.2 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 0.1 | 1.0 | GO:0001553 | luteinization(GO:0001553) |
| 0.1 | 1.4 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.1 | 0.2 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.1 | 0.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
| 0.1 | 0.4 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.1 | 4.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.1 | 2.3 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.1 | 0.3 | GO:0015749 | hexose transport(GO:0008645) monosaccharide transport(GO:0015749) |
| 0.1 | 0.2 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 | 1.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 | 0.4 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.1 | 0.3 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.1 | 0.3 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.1 | 1.2 | GO:0009620 | response to fungus(GO:0009620) defense response to fungus(GO:0050832) |
| 0.1 | 0.2 | GO:0071423 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.1 | 1.1 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 | 1.6 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 1.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
| 0.1 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.1 | 1.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 | 1.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.1 | 9.3 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.1 | 1.2 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.6 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.1 | 0.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 1.4 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.1 | 0.3 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
| 0.1 | 9.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.3 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.1 | 0.8 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.1 | 0.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.1 | 0.1 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 0.2 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
| 0.1 | 5.2 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 | 3.6 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.1 | 0.4 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 | 1.5 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.1 | 0.2 | GO:0045185 | maintenance of protein location(GO:0045185) |
| 0.1 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.7 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.1 | 0.6 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 1.7 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
| 0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 0.1 | 0.9 | GO:0035082 | axoneme assembly(GO:0035082) |
| 0.1 | 0.3 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 | 1.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
| 0.1 | 0.7 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
| 0.1 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.1 | 0.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.1 | 2.9 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
| 0.1 | 0.3 | GO:0044782 | cilium organization(GO:0044782) |
| 0.1 | 0.3 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.1 | 0.4 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.1 | 0.3 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 | 0.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.1 | 0.4 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 | 1.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.1 | 0.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 | 0.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 | 0.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.1 | 0.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 | 1.2 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.1 | 0.9 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 4.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.1 | 0.2 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.2 | GO:0061743 | motor learning(GO:0061743) |
| 0.1 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.1 | 0.8 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.1 | 0.9 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.5 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 | 1.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.2 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
| 0.1 | 10.2 | GO:0007286 | spermatid development(GO:0007286) |
| 0.1 | 0.2 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 | 0.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 0.1 | 1.2 | GO:0098760 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
| 0.1 | 0.3 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.1 | 1.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.2 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 0.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
| 0.1 | 1.4 | GO:0031054 | pre-miRNA processing(GO:0031054) |
| 0.1 | 0.8 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
| 0.1 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 | 0.2 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 0.1 | 1.0 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
| 0.1 | 0.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 | 0.5 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 | 1.8 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.1 | 0.4 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.1 | 0.3 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.1 | 0.8 | GO:0045623 | negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of alpha-beta T cell differentiation(GO:0046639) |
| 0.1 | 0.4 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.1 | 0.2 | GO:0001562 | response to protozoan(GO:0001562) |
| 0.1 | 0.5 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 0.1 | 0.8 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.5 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.1 | 1.0 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 | 0.4 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
| 0.1 | 0.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 1.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.1 | 0.3 | GO:0048698 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 | 2.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.1 | 0.4 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
| 0.1 | 2.0 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
| 0.1 | 1.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.1 | 0.3 | GO:0072017 | distal tubule development(GO:0072017) |
| 0.1 | 0.6 | GO:0014870 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) |
| 0.1 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 0.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.1 | 0.1 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 0.1 | 0.1 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 1.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.2 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.1 | 0.5 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 1.4 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.1 | 0.5 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
| 0.1 | 0.1 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 1.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 0.5 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 0.1 | 5.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 | 0.2 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.1 | 1.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 2.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 | 0.1 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.1 | 0.3 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 | 0.3 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.1 | 0.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 0.5 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 | 0.1 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.1 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 | 0.9 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.1 | 0.1 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.3 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.1 | 0.4 | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
| 0.1 | 0.3 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 | 0.4 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
| 0.1 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 | 0.2 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.1 | 0.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.1 | 0.2 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.1 | 0.6 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 | 0.2 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 0.1 | 0.3 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.1 | 0.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.1 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.1 | 0.1 | GO:0036005 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.1 | 0.7 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
| 0.1 | 1.8 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 0.1 | 1.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 0.5 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 | 0.5 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.1 | 0.1 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 | 0.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 | 0.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 2.6 | GO:0021795 | cerebral cortex cell migration(GO:0021795) |
| 0.1 | 0.9 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 | 0.2 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.1 | 0.2 | GO:0009299 | mRNA transcription(GO:0009299) |
| 0.1 | 0.3 | GO:0032621 | interleukin-18 production(GO:0032621) |
| 0.1 | 0.4 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
| 0.1 | 0.9 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.1 | 1.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.1 | 0.6 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 | 2.9 | GO:0009154 | purine ribonucleotide catabolic process(GO:0009154) |
| 0.1 | 0.1 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
| 0.1 | 0.1 | GO:0035435 | phosphate ion transport(GO:0006817) phosphate ion transmembrane transport(GO:0035435) |
| 0.1 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.7 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.1 | 1.6 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.1 | 1.6 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.2 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.1 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 | 0.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.1 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.1 | 1.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.1 | 0.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 | 1.8 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.1 | 0.1 | GO:0045851 | pH reduction(GO:0045851) intracellular pH reduction(GO:0051452) |
| 0.1 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.9 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
| 0.1 | 0.2 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
| 0.1 | 0.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.4 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
| 0.1 | 0.1 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.1 | 0.1 | GO:0033504 | floor plate development(GO:0033504) |
| 0.1 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 0.1 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 1.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.7 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 | 0.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.0 | 3.0 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 0.0 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.0 | 0.2 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.0 | 0.9 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
| 0.0 | 0.2 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.0 | 0.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) cellular response to UV-A(GO:0071492) |
| 0.0 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.0 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.2 | GO:0042107 | cytokine metabolic process(GO:0042107) |
| 0.0 | 0.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 0.0 | 3.7 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
| 0.0 | 0.2 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.0 | 0.0 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.0 | 0.1 | GO:0010165 | response to X-ray(GO:0010165) |
| 0.0 | 0.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.0 | 0.4 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.0 | 0.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.0 | 0.2 | GO:2000170 | regulation of renal output by angiotensin(GO:0002019) negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.0 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.0 | 0.4 | GO:0050482 | icosanoid secretion(GO:0032309) arachidonic acid secretion(GO:0050482) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) arachidonate transport(GO:1903963) |
| 0.0 | 0.3 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.0 | 0.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
| 0.0 | 0.1 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.0 | 0.4 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.0 | 0.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.0 | 0.3 | GO:0009267 | cellular response to starvation(GO:0009267) |
| 0.0 | 0.0 | GO:0009080 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.0 | 0.3 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.0 | 0.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.0 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.0 | 0.2 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 | 0.1 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.0 | 0.4 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) neurotransmitter reuptake(GO:0098810) |
| 0.0 | 0.1 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 0.0 | 0.2 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 | 0.3 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.0 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.0 | 1.2 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.0 | 0.5 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.1 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.0 | 0.0 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.0 | 0.6 | GO:0010043 | response to zinc ion(GO:0010043) |
| 0.0 | 0.2 | GO:0016246 | RNA interference(GO:0016246) |
| 0.0 | 0.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.0 | 0.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 | 0.2 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.0 | 0.1 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 | 0.1 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.0 | 0.1 | GO:0048611 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.0 | 1.1 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 | 0.1 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.0 | 0.3 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.0 | 0.1 | GO:1904798 | positive regulation of core promoter binding(GO:1904798) |
| 0.0 | 0.1 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
| 0.0 | 0.2 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 | 0.2 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.0 | 0.5 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.0 | 0.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.0 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.0 | 0.0 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.0 | 0.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 | 0.2 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
| 0.0 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.0 | 0.4 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
| 0.0 | 0.5 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.0 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.0 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.0 | 1.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.2 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.0 | 0.4 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 | 0.3 | GO:0007276 | gamete generation(GO:0007276) |
| 0.0 | 0.5 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.0 | 0.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.0 | 0.2 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
| 0.0 | 0.8 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
| 0.0 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.0 | 0.0 | GO:0002001 | renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure(GO:0001999) renin secretion into blood stream(GO:0002001) regulation of renin secretion into blood stream(GO:1900133) |
| 0.0 | 0.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.1 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.0 | 0.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.0 | 0.0 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
| 0.0 | 0.1 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 0.0 | 0.5 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.2 | GO:0009988 | cell-cell recognition(GO:0009988) |
| 0.0 | 0.3 | GO:0070166 | enamel mineralization(GO:0070166) |
| 0.0 | 0.5 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.0 | 0.4 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.0 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.0 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.0 | 0.4 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.0 | 0.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.0 | 0.1 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.0 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.0 | 0.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 | 0.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 0.0 | 0.2 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.0 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.0 | 0.1 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.1 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.0 | 0.1 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.0 | 0.1 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
| 0.0 | 0.2 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.0 | 0.2 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.7 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.0 | 0.1 | GO:0030033 | microvillus assembly(GO:0030033) |
| 0.0 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) regulation of kinetochore assembly(GO:0090234) |
| 0.0 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
| 0.0 | 0.1 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.0 | 0.3 | GO:0071625 | vocalization behavior(GO:0071625) |
| 0.0 | 0.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.7 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.0 | 0.0 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
| 0.0 | 0.1 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.0 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.0 | 0.3 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.0 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.0 | 0.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.0 | 0.1 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.0 | 0.1 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.0 | 1.2 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.1 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.0 | 0.3 | GO:0051894 | positive regulation of focal adhesion assembly(GO:0051894) |
| 0.0 | 3.9 | GO:0030072 | peptide hormone secretion(GO:0030072) |
| 0.0 | 0.2 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.0 | 0.7 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.0 | 0.5 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.0 | 1.1 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
| 0.0 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.0 | 1.3 | GO:0006024 | aminoglycan biosynthetic process(GO:0006023) glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 | 0.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.0 | 0.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.0 | 0.5 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 | 0.8 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.0 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 0.1 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 0.0 | 0.0 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.0 | 0.1 | GO:0009409 | response to cold(GO:0009409) |
| 0.0 | 0.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.1 | GO:0030850 | prostate gland development(GO:0030850) |
| 0.0 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 | 0.2 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.0 | 0.3 | GO:0046324 | regulation of glucose import(GO:0046324) |
| 0.0 | 0.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.0 | 0.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.0 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 | 0.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
| 0.0 | 0.1 | GO:0045078 | regulation of interferon-gamma biosynthetic process(GO:0045072) positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.0 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.0 | 0.1 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.0 | 0.3 | GO:0097503 | sialylation(GO:0097503) |
| 0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.0 | 0.1 | GO:1990034 | calcium ion export from cell(GO:1990034) |
| 0.0 | 1.0 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.0 | 0.2 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.0 | 0.1 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 | 0.1 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.0 | 0.1 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.0 | 0.1 | GO:0060433 | bronchus development(GO:0060433) lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
| 0.0 | 0.0 | GO:0072207 | metanephric epithelium development(GO:0072207) |
| 0.0 | 0.5 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.0 | 1.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.0 | 0.0 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.0 | 0.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 | 0.2 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.0 | 0.2 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.0 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) regulation of neuromuscular junction development(GO:1904396) |
| 0.0 | 0.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 0.0 | 0.2 | GO:1902624 | positive regulation of neutrophil migration(GO:1902624) |
| 0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.0 | 0.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.0 | 0.1 | GO:0030070 | insulin processing(GO:0030070) |
| 0.0 | 0.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.0 | 0.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.1 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.0 | 0.9 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.0 | 0.4 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 | 0.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.0 | 0.0 | GO:0033363 | secretory granule organization(GO:0033363) |
| 0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 3.3 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.0 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.0 | 0.1 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
| 0.0 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
| 0.0 | 0.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.1 | GO:0038042 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) |
| 0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.1 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.0 | 0.2 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.0 | 0.1 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
| 0.0 | 0.1 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 | 0.0 | GO:0006643 | membrane lipid metabolic process(GO:0006643) |
| 0.0 | 1.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 | 0.3 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.0 | 0.1 | GO:0097066 | response to thyroid hormone(GO:0097066) cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 | 0.6 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 0.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
| 0.0 | 0.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 | 0.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.0 | 0.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.6 | 3.6 | GO:0051233 | spindle midzone(GO:0051233) |
| 3.3 | 10.0 | GO:0001534 | radial spoke(GO:0001534) |
| 2.6 | 47.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 1.8 | 9.1 | GO:0098536 | deuterosome(GO:0098536) |
| 1.7 | 11.6 | GO:0070695 | FHF complex(GO:0070695) |
| 1.3 | 4.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 1.3 | 6.7 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 1.2 | 1.2 | GO:0036128 | CatSper complex(GO:0036128) |
| 1.2 | 3.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 1.1 | 3.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 1.0 | 21.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.0 | 2.0 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.9 | 4.5 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.9 | 2.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.8 | 2.4 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.8 | 3.9 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.8 | 7.5 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.7 | 6.6 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.7 | 3.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.7 | 0.7 | GO:1902911 | protein kinase complex(GO:1902911) |
| 0.7 | 6.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.7 | 2.1 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.7 | 3.4 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.7 | 4.7 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.7 | 4.0 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.7 | 8.7 | GO:0097433 | dense body(GO:0097433) |
| 0.7 | 6.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 0.6 | 5.1 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.6 | 3.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.6 | 8.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.6 | 2.5 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.6 | 4.3 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.6 | 2.9 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.6 | 2.9 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.6 | 2.3 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.6 | 17.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.5 | 1.1 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 0.5 | 4.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.5 | 2.8 | GO:0043226 | organelle(GO:0043226) |
| 0.5 | 56.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.4 | 1.3 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.4 | 15.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.4 | 1.7 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.4 | 0.8 | GO:0031253 | cell projection membrane(GO:0031253) |
| 0.4 | 2.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.4 | 0.4 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
| 0.4 | 1.1 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.4 | 1.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.4 | 2.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.4 | 2.8 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.4 | 1.8 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.3 | 1.0 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
| 0.3 | 1.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 0.3 | 3.3 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.3 | 3.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.3 | 2.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.3 | 7.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.3 | 1.5 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.3 | 7.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
| 0.3 | 1.5 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.3 | 7.2 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.3 | 1.8 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.3 | 0.9 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.3 | 0.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.3 | 1.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.3 | 1.9 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 5.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.3 | 0.3 | GO:0044753 | amphisome(GO:0044753) |
| 0.3 | 0.8 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.3 | 0.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.3 | 4.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 0.2 | GO:0044301 | climbing fiber(GO:0044301) |
| 0.2 | 1.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.2 | 7.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 1.4 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 0.2 | 0.7 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.2 | 1.4 | GO:0045179 | apical cortex(GO:0045179) |
| 0.2 | 4.0 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 1.2 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 1.6 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.2 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.2 | 2.3 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 0.5 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.2 | 0.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.2 | 3.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.2 | 1.1 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.2 | 2.0 | GO:0031105 | septin complex(GO:0031105) |
| 0.2 | 5.8 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 1.1 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.2 | 0.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 0.6 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.2 | 3.3 | GO:0002102 | podosome(GO:0002102) |
| 0.2 | 0.8 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 12.3 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 0.8 | GO:0097196 | Shu complex(GO:0097196) |
| 0.2 | 0.6 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.2 | 1.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.2 | 9.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.2 | 8.4 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.2 | 13.1 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.2 | 2.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.2 | 0.6 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.2 | 27.8 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 3.0 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.2 | 5.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 0.2 | 1.7 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.2 | 16.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 0.2 | GO:0000785 | chromatin(GO:0000785) |
| 0.2 | 5.4 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.2 | 4.5 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.2 | 1.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.2 | 0.5 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.2 | 1.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.2 | 1.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.2 | 3.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.2 | 0.6 | GO:0031673 | H zone(GO:0031673) |
| 0.2 | 0.6 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.2 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.2 | 0.5 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.2 | 4.4 | GO:0000145 | exocyst(GO:0000145) |
| 0.1 | 2.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.1 | 4.9 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 2.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 1.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 1.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 0.4 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.7 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.1 | 1.0 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.4 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.1 | 2.8 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 1.1 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 9.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 1.2 | GO:0043203 | axon hillock(GO:0043203) |
| 0.1 | 0.5 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.1 | 0.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.1 | 1.0 | GO:0043196 | varicosity(GO:0043196) |
| 0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 0.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 11.4 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 0.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.1 | 5.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.1 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.1 | 0.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.1 | 0.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 1.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.1 | 4.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.5 | GO:1990745 | EARP complex(GO:1990745) |
| 0.1 | 1.6 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 1.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.1 | 0.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 0.1 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.1 | 1.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 0.7 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 0.3 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.1 | 3.8 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 1.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.1 | 0.3 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.1 | 0.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.1 | 1.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 6.7 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.1 | 0.4 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 4.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.1 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.1 | 3.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.1 | 0.5 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.1 | 8.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
| 0.1 | 1.3 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.1 | 0.8 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.1 | 0.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 0.6 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.1 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 8.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 2.1 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.1 | 1.7 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 6.8 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 1.2 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) proton-transporting V-type ATPase complex(GO:0033176) |
| 0.1 | 0.1 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.1 | 0.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.1 | 0.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 0.8 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.1 | 0.7 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.1 | 0.3 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.1 | 12.3 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.1 | 1.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 2.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.1 | 0.2 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.1 | 1.2 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.1 | 0.6 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 1.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.1 | 0.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 0.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.1 | 0.3 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.1 | 0.2 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.1 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 2.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
| 0.1 | 4.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 0.8 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.1 | 2.7 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.1 | 1.3 | GO:0043234 | protein complex(GO:0043234) |
| 0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.1 | 0.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 7.6 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.1 | 1.5 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 2.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.1 | 0.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.1 | 1.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
| 0.1 | 2.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.1 | 1.0 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.1 | 1.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 1.5 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.1 | 2.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.1 | 4.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
| 0.1 | 0.6 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 4.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 1.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.1 | 0.2 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.1 | 0.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 3.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 2.4 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.1 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.1 | 10.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.1 | 0.2 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.1 | 5.1 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 2.7 | GO:0044438 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
| 0.1 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.8 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.1 | 0.9 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.2 | GO:0034455 | t-UTP complex(GO:0034455) |
| 0.0 | 0.4 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 1.8 | GO:0090544 | BAF-type complex(GO:0090544) |
| 0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.0 | 0.4 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.0 | 0.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
| 0.0 | 3.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.0 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.0 | 1.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.0 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
| 0.0 | 0.1 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
| 0.0 | 0.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.0 | 0.2 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
| 0.0 | 0.2 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.0 | 0.4 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.0 | 1.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 0.8 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.0 | 0.9 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 0.7 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
| 0.0 | 0.5 | GO:0005604 | basement membrane(GO:0005604) |
| 0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.0 | 14.9 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 0.5 | GO:0030904 | retromer complex(GO:0030904) |
| 0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 4.1 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.0 | 0.2 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.0 | 0.2 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.0 | 0.1 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.2 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.0 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
| 0.0 | 1.3 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.0 | 0.2 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 4.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.0 | 0.2 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 0.3 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.3 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
| 0.0 | 4.9 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
| 0.0 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 2.9 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.0 | 0.1 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.0 | 0.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.3 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.1 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.0 | 0.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
| 0.0 | 3.4 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 0.2 | GO:1902555 | endoribonuclease complex(GO:1902555) |
| 0.0 | 6.5 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.0 | 0.1 | GO:0005844 | polysome(GO:0005844) |
| 0.0 | 0.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
| 0.0 | 0.3 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 0.0 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.0 | 1.5 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 0.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.0 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.0 | 0.3 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 0.2 | GO:0044754 | autolysosome(GO:0044754) |
| 0.0 | 0.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.0 | 3.3 | GO:0005929 | cilium(GO:0005929) |
| 0.0 | 8.3 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
| 0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.0 | 0.1 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 0.0 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.0 | 0.1 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.0 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
| 0.0 | 0.1 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.0 | 0.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.0 | 0.0 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.0 | 0.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.0 | 0.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.0 | 0.3 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.0 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.0 | 0.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.0 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
| 0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.0 | 0.3 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.3 | 21.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 3.6 | 10.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 3.3 | 10.0 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 2.7 | 8.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 2.6 | 12.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 1.9 | 7.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 1.8 | 5.5 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.6 | 4.7 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
| 1.6 | 10.9 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 1.4 | 1.4 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 1.4 | 4.2 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 1.4 | 9.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 1.3 | 10.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 1.2 | 6.0 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 1.1 | 5.7 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 1.1 | 4.5 | GO:0047708 | biotinidase activity(GO:0047708) |
| 1.1 | 6.5 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
| 1.0 | 3.9 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 1.0 | 5.8 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) chondroitin 4-sulfotransferase activity(GO:0047756) |
| 1.0 | 3.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 1.0 | 2.9 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 0.9 | 1.9 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.9 | 17.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.9 | 3.7 | GO:0004040 | amidase activity(GO:0004040) |
| 0.9 | 2.8 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.9 | 20.7 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.9 | 6.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.9 | 3.5 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.8 | 1.7 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 0.8 | 7.3 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.8 | 3.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.8 | 6.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.8 | 3.9 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.8 | 10.7 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.8 | 53.9 | GO:0042805 | actinin binding(GO:0042805) |
| 0.8 | 3.0 | GO:0016160 | amylase activity(GO:0016160) |
| 0.7 | 4.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.7 | 4.3 | GO:0004473 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
| 0.7 | 5.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 0.7 | 4.2 | GO:0045118 | azole transporter activity(GO:0045118) |
| 0.7 | 2.8 | GO:0031849 | olfactory receptor binding(GO:0031849) |
| 0.7 | 6.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.7 | 2.7 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.7 | 7.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.7 | 8.0 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.6 | 2.4 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 0.6 | 1.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.6 | 7.6 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.6 | 0.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.6 | 2.9 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
| 0.6 | 5.1 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.6 | 1.7 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.6 | 3.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.6 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.5 | 3.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.5 | 2.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.5 | 5.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 0.5 | 1.5 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.5 | 1.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.5 | 1.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.5 | 4.6 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.5 | 2.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.5 | 1.5 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.5 | 2.5 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
| 0.5 | 1.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.5 | 2.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.5 | 1.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.5 | 1.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.5 | 1.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.5 | 1.4 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
| 0.5 | 2.4 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.5 | 5.6 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.5 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.5 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.5 | 2.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 0.4 | 1.3 | GO:0047322 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.4 | 16.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 0.4 | 5.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.4 | 4.5 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.4 | 1.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.4 | 1.3 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.4 | 3.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.4 | 2.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.4 | 2.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.4 | 3.0 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.4 | 2.5 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.4 | 2.1 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.4 | 2.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 0.4 | 2.9 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 0.4 | 1.2 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.4 | 2.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.4 | 6.5 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.4 | 2.0 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.4 | 1.2 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.4 | 3.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.4 | 1.2 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.4 | 3.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.4 | 1.5 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.4 | 5.0 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.4 | 0.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.4 | 4.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 1.1 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.4 | 1.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.4 | 1.1 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.4 | 2.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.4 | 1.1 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 0.4 | 14.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.4 | 0.4 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.4 | 1.4 | GO:0004504 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.3 | 1.4 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.3 | 1.0 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.3 | 1.7 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.3 | 1.0 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.3 | 0.7 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
| 0.3 | 1.0 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.3 | 1.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
| 0.3 | 3.3 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.3 | 7.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.3 | 2.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.3 | 4.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 0.3 | 1.0 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.3 | 1.0 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.3 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.3 | 3.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.3 | 0.9 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
| 0.3 | 3.4 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
| 0.3 | 3.1 | GO:0030882 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.3 | 4.9 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 0.3 | 4.8 | GO:0015250 | water channel activity(GO:0015250) |
| 0.3 | 11.0 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.3 | 0.9 | GO:0031859 | platelet activating factor receptor binding(GO:0031859) |
| 0.3 | 2.6 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 0.9 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.3 | 1.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.3 | 5.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.3 | 7.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.3 | 7.6 | GO:0005112 | Notch binding(GO:0005112) |
| 0.3 | 1.9 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.3 | 9.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.3 | 1.7 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 1.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.3 | 4.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.3 | 1.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 1.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.3 | 1.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.3 | 1.3 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.3 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.3 | 8.0 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.3 | 0.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 5.4 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.3 | 0.8 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.3 | 0.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 0.2 | 0.2 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.2 | 3.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.2 | 0.7 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 0.2 | 1.0 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 0.2 | 0.7 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.2 | 1.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.2 | 1.0 | GO:0051800 | phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.2 | 5.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 0.9 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.2 | 1.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.2 | 0.7 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.2 | 0.9 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.2 | 1.6 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.2 | 9.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 1.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 1.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.2 | 0.9 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.2 | 1.3 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.2 | 2.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.2 | 9.9 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.2 | 3.1 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.2 | 2.4 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.2 | 1.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 1.5 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.2 | 2.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.2 | 2.7 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.2 | 1.0 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 0.2 | 1.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) |
| 0.2 | 0.6 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.2 | 0.6 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
| 0.2 | 1.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.2 | 0.6 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.2 | 1.6 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 1.8 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 2.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.2 | 0.6 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.2 | 1.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.2 | 0.6 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.2 | 4.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.2 | 0.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.2 | 7.9 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.2 | 0.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.2 | 1.2 | GO:0033989 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.2 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.2 | 2.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 5.9 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 0.6 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
| 0.2 | 0.9 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.2 | 0.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.2 | 0.7 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.2 | 1.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.2 | 0.5 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.2 | 9.2 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.2 | 3.0 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.2 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.2 | 1.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 2.3 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 1.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.2 | 1.2 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 2.7 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.2 | 1.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 2.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.2 | 1.0 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.2 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.2 | 1.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.2 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.2 | 0.8 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 1.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.2 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.2 | 2.4 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.2 | 1.1 | GO:0015315 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.1 | 1.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.1 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 2.7 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 0.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.1 | 1.9 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 11.1 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 0.4 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
| 0.1 | 4.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.1 | 0.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 0.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.1 | 2.7 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 1.7 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.1 | 3.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.1 | 0.4 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.1 | 0.4 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 0.4 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
| 0.1 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.1 | 1.7 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.1 | 1.0 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.1 | 0.1 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.1 | 1.7 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
| 0.1 | 0.6 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.1 | 1.7 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 4.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.5 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 0.1 | 5.0 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 0.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
| 0.1 | 1.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.1 | 0.4 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.1 | 0.5 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.1 | 0.2 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.1 | 0.4 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 0.1 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.4 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.1 | 1.0 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.1 | 0.7 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.1 | 0.4 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.1 | 8.4 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.1 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.1 | 0.9 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.1 | 0.3 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 0.1 | 1.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 0.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 0.1 | 2.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.1 | 1.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 0.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.1 | 0.9 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 0.3 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 0.7 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.1 | 1.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 1.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 0.4 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.1 | 1.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.2 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 0.1 | 0.3 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 1.5 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
| 0.1 | 1.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.1 | 0.5 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 0.5 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 0.1 | 0.4 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 0.2 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.1 | 0.8 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 0.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.1 | 0.4 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.1 | 0.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
| 0.1 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 0.1 | 0.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
| 0.1 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 1.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 0.1 | 0.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.1 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.1 | 0.5 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.1 | 1.6 | GO:0043621 | protein self-association(GO:0043621) |
| 0.1 | 0.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 0.1 | 0.3 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.1 | 1.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.1 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.1 | 0.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.1 | 0.3 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
| 0.1 | 0.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.1 | 3.5 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 3.9 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.1 | 0.8 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.1 | 1.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 6.5 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 0.3 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.1 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 0.4 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.1 | 0.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 0.9 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.4 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.1 | 1.9 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.1 | 0.4 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.1 | 0.3 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.1 | 0.3 | GO:0098639 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.1 | 4.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.1 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.1 | 0.2 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.1 | 1.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.1 | 0.3 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.3 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.3 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.1 | 0.1 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.1 | 0.8 | GO:0019864 | IgG binding(GO:0019864) |
| 0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.1 | 0.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.2 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.1 | 0.6 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 0.1 | 0.2 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
| 0.1 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.1 | 1.3 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
| 0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.1 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.1 | 1.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 2.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.1 | 0.2 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 0.1 | 0.4 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 0.5 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 1.7 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
| 0.1 | 0.4 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.1 | 0.6 | GO:0031420 | alkali metal ion binding(GO:0031420) |
| 0.1 | 0.8 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.1 | 0.1 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 7.7 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 0.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 0.2 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 0.1 | 1.0 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
| 0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 0.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.1 | 0.5 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 0.5 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.1 | 0.2 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.1 | 0.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.1 | 0.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 0.3 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.1 | 0.3 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.1 | 0.9 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.1 | 0.9 | GO:0016594 | glycine binding(GO:0016594) |
| 0.1 | 0.6 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.1 | 0.2 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.1 | 0.6 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.1 | 0.8 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
| 0.1 | 2.4 | GO:0015248 | sterol transporter activity(GO:0015248) |
| 0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 0.2 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.1 | 0.2 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.2 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.1 | 1.5 | GO:0046961 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.1 | 0.7 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.1 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 1.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
| 0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.1 | 1.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
| 0.1 | 2.2 | GO:0042287 | MHC protein binding(GO:0042287) |
| 0.1 | 2.0 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 1.0 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.1 | 0.2 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
| 0.1 | 0.1 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.1 | 1.1 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.1 | 3.7 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.1 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.1 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.2 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.1 | 0.1 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.1 | 2.1 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.1 | 0.1 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.1 | 1.9 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
| 0.1 | 0.3 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.1 | 6.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
| 0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 0.2 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.1 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.1 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 1.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 4.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.1 | 0.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.0 | 0.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.0 | 0.2 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.0 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
| 0.0 | 0.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 0.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.0 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.4 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.0 | 1.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.2 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 1.2 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.4 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.0 | 0.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 1.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.0 | 0.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.0 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.0 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.5 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.4 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.0 | 0.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.0 | 0.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 3.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.0 | 0.0 | GO:0002134 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.0 | 0.1 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.0 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.0 | 0.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.0 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.0 | 0.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 2.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.0 | 24.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.0 | 0.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.0 | 0.1 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.0 | 0.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 0.0 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
| 0.0 | 0.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.0 | 0.5 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.0 | 0.1 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.0 | 2.1 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.0 | 0.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.2 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.0 | 0.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
| 0.0 | 0.3 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 0.0 | 0.1 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.0 | 0.3 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.0 | 0.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.0 | 0.5 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.1 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
| 0.0 | 0.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.1 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.3 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.0 | 3.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.0 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.0 | 0.3 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.0 | 0.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.0 | 0.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.0 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.0 | 0.2 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
| 0.0 | 5.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 1.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.0 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.0 | 1.3 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 0.0 | 0.1 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.0 | 0.1 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.0 | 1.0 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.0 | 0.2 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.0 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.0 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.0 | 0.8 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.0 | 0.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.3 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 2.0 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
| 0.0 | 0.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.0 | 0.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.0 | 0.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.0 | 0.3 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.0 | 0.2 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.0 | 0.1 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.0 | 1.2 | GO:0051087 | chaperone binding(GO:0051087) |
| 0.0 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.0 | 0.1 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
| 0.0 | 0.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.0 | 0.2 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.0 | 0.1 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.0 | 1.2 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.5 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.0 | 0.3 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.0 | 0.0 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 0.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.0 | 0.1 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.0 | 0.1 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 1.0 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.0 | 0.1 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.0 | 0.0 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.0 | 0.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.2 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.1 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 0.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.0 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.1 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.0 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
| 0.0 | 0.2 | GO:0043495 | protein anchor(GO:0043495) |
| 0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.0 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 0.1 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.0 | 0.1 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
| 0.0 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
| 0.0 | 0.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 2.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.0 | 0.0 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.0 | 0.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.0 | 0.1 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.5 | 5.9 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.4 | 34.2 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.4 | 6.9 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.4 | 5.6 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.4 | 2.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.4 | 4.0 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 0.4 | 5.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 0.7 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.2 | 2.9 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.2 | 0.2 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.2 | 12.0 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 0.2 | 1.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.1 | 5.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 2.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.1 | 0.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 1.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.1 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 4.4 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.1 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 1.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 1.1 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 0.4 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 14.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 0.8 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.1 | 1.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.1 | 3.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.1 | 2.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 1.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 3.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.1 | 4.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.9 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 0.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.1 | 1.9 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.1 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 0.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.1 | 3.3 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.7 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
| 0.0 | 3.4 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 2.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.6 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.0 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 10.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 0.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.0 | 1.6 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 1.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.5 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 1.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.6 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
| 0.0 | 0.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.0 | 7.0 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.5 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.0 | 0.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.0 | 2.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 1.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.0 | 1.0 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.0 | 0.5 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.0 | 0.1 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.2 | 13.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.8 | 24.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.8 | 14.5 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.7 | 15.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.6 | 9.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.6 | 10.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.5 | 6.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.5 | 7.6 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.5 | 5.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.5 | 2.8 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.4 | 14.4 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 0.4 | 10.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.4 | 15.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.4 | 6.1 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.4 | 14.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.3 | 3.0 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.3 | 3.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.3 | 8.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 8.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 0.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.2 | 2.2 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.2 | 4.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 7.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 8.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 4.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 0.2 | 2.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.2 | 22.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.2 | 10.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 1.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 3.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.2 | 0.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.2 | 3.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 4.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.2 | 1.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.2 | 2.3 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.2 | 3.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 0.2 | 3.7 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.1 | 3.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 4.4 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 3.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.1 | 2.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 3.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.1 | 2.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 10.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 8.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 2.1 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.1 | 1.9 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 1.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 0.2 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
| 0.1 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 4.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.1 | 3.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 4.3 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.1 | 1.3 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.1 | 9.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.1 | 1.3 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.1 | 0.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 4.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
| 0.1 | 1.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.1 | 1.8 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
| 0.1 | 1.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 0.1 | 1.4 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.1 | 0.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.1 | 1.5 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 0.7 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.1 | 0.3 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 5.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 0.7 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.1 | 1.8 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 3.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.1 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 1.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.0 | 18.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 1.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.0 | 1.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.0 | 4.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 1.3 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
| 0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.0 | 2.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.7 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.0 | 1.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 0.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.0 | 1.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.0 | 6.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 2.5 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 2.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.0 | 0.4 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.0 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.0 | 0.7 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.0 | 0.4 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
| 0.0 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.0 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 0.3 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
| 0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.0 | 0.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.0 | 0.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
| 0.0 | 0.3 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |